Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7594 Inhaled Formulation in Healthy Japanese Men [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and pharmacokinetics of AZD7594 inhaled formulation in healthy Japanese men; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD7594

Snippet

Sponsor: AstraZeneca | Conditions: Asthma, Chronic Obstructive Pulmonary Disease COPD | Phase 1 | Status: COMPLETED | Results posted: 2018-02-19